Загрузка...
Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients
Ovarian cancer (OC) is an important cause of gynecologic cancer-related deaths. In Mexico, around 4700 new cases of OC are diagnosed per year and it represents the second cause of gynecological cancer mortality with more than 2700 deaths. Germline mutations in BRCA1/2 genes are present in 13–18% of...
Сохранить в:
| Опубликовано в: : | Transl Oncol |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Neoplasia Press
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6931216/ https://ncbi.nlm.nih.gov/pubmed/31869745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.11.003 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|